首页> 美国卫生研究院文献>PLoS Pathogens >HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G
【2h】

HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G

机译:HIV-1适应性研究揭示了一种新的Env介导的体内稳态机制可避免APOBEC3G致死性超突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

HIV-1 replication normally requires Vif-mediated neutralization of APOBEC3 antiviral enzymes. Viruses lacking Vif succumb to deamination-dependent and -independent restriction processes. Here, HIV-1 adaptation studies were leveraged to ask whether viruses with an irreparable vif deletion could develop resistance to restrictive levels of APOBEC3G. Several resistant viruses were recovered with multiple amino acid substitutions in Env, and these changes alone are sufficient to protect Vif-null viruses from APOBEC3G-dependent restriction in T cell lines. Env adaptations cause decreased fusogenicity, which results in higher levels of Gag-Pol packaging. Increased concentrations of packaged Pol in turn enable faster virus DNA replication and protection from APOBEC3G-mediated hypermutation of viral replication intermediates. Taken together, these studies reveal that a moderate decrease in one essential viral activity, namely Env-mediated fusogenicity, enables the virus to change other activities, here, Gag-Pol packaging during particle production, and thereby escape restriction by the antiviral factor APOBEC3G. We propose a new paradigm in which alterations in viral homeostasis, through compensatory small changes, constitute a general mechanism used by HIV-1 and other viral pathogens to escape innate antiviral responses and other inhibitions including antiviral drugs.
机译:HIV-1复制通常需要Vif介导的APOBEC3抗病毒酶的中和。缺乏Vif的病毒会屈服于脱氨依赖性和非限制性限制性过程。在这里,利用HIV-1适应性研究来询问具有无法修复的vif缺失的病毒是否会对耐药水平的APOBEC3G产生抗药性。在Env中用多个氨基酸取代回收了几种抗药性病毒,仅这些改变就足以保护Vif-null病毒免受T细胞系中APOBEC3G依赖性限制。 Env适应会导致融合性降低,从而导致Gag-Pol包装的水平更高。包装的Pol浓度的增加反过来又可以使病毒DNA更快地复制,并免受APOBEC3G介导的病毒复制中间体超突变的影响。综上所述,这些研究表明,一种基本病毒活性(即Env介导的融合性)的适度降低使病毒能够改变其他活性,在此过程中,颗粒生产过程中的Gag-Pol包装,从而摆脱了抗病毒因子APOBEC3G的限制。我们提出了一个新的范式,其中通过补偿性小变化改变病毒稳态,构成了HIV-1和其他病毒病原体逃避先天抗病毒反应和其他抑制作用(包括抗病毒药)使用的一般机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号